Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive…
Tuesday, February 4
Trending
- RISE PECO World Summit 2025 Kicks Off with Visionary Call for Global Collaboration
- United by Unique: Expert’s Advice on Personalized Cancer Care for World Cancer Day 2025
- Budget Boosts India’s Economic Growth
- Chamunda Electrical Limited Raises Rs 411.00 Lakhs from Anchor Investors Ahead of its IPO
- SarkarSEO Launches a New Era of Search Everywhere Optimization
- Perfext Nutraceutical all set to Drive Growth: India’s Nutraceutical Market to Reach USD 18 Billion by 2025
- Bridging the Mentorship Gap: Lessons for a Global Startup Ecosystem By Prakhar Mittal
- ICEXPO Announces Pharma Live Expo 2025: A Key Event for Pharma & MedTech in Mumbai, April 17-19
